Retour aux appels d'offres

Composés de gélatine, solutions intraveineuses et additifs, solvants et diluants pour solutions intraveineuses, et solutions de nutrition parentérale

Ouvert
Date limite
15 jours restants
Mars 17, 2026
Détails du contrat
Catégorie
Fournitures
Référence
306019
Valeur
€981,800
Lieu
Estonia, Estonie
Publié
Février 12, 2026
Code CPV
Critères d'évaluation
24-month estimated cost of the tender part100%
Calendrier du projet

Publication de l'appel d'offres

Février 12, 2026

Date limite pour les questions

Mars 10, 2026

Date limite de soumission

Mars 17, 2026

Ouverture de l'appel d'offres

Mars 17, 2026

Probabilité de gainPRO
🔒
Passer au Professionnel
Consultez votre probabilité de gain estimée basée sur les données historiques.
Passer au Professionnel →
Intelligence acheteurPRO
🔒
Débloquer l'intelligence acheteur
Consultez les modèles de dépenses, les procédures préférées et plus encore.
Passer au Professionnel →
Aperçu du secteurPRO
🔒
Débloquer les aperçus du secteur
Consultez les prix gagnants moyens, les niveaux de concurrence et les tendances du marché.
Passer au Professionnel →
Budget
€981,800
Durée
Non spécifié
Lieu
Estonia
Type
Fournitures
76
Score de qualité/100
Bon
Référentiel de marché
Prix moyen gagnant
€92,792
Offres moyennes
2.2
Concurrence
Faible
PME gagnantes
86%
3,220 appels d'offres analysés

Description originale de l'appel d'offres

Achat de composés de gélatine, de solutions intraveineuses et de leurs additifs, de solvants et de diluants, et de solutions de nutrition parentérale sur une période de 24 mois, selon les besoins réels.
Soumission électronique

Analyse des risques

Veuillez vous connecter pour utiliser l'analyse des risques.

Se connecter

Stratégie gagnante

Connectez-vous pour accéder aux recommandations de stratégie gagnante.

Se connecter

Concurrents

Passez à un plan supérieur pour voir quelles entreprises sont susceptibles de soumissionner pour cet appel d'offres, basé sur les données historiques.

Se connecter

Exigences et qualifications

13 exigences dans 5 catégories

Soumission (5)
Obligatoire (2)
Conformité (2)
Technique (2)
Financier (2)
SUBMISSION REQUIREMENTS5
--The bid must be submitted according to the general tender conditions and the e-procurement process.
--Complete and submit Form 1 (application for participation in public procurement).
--Complete and submit Form 2 (technical specification and price breakdown table).
MANDATORY EXCLUSION GROUNDS2
--Bidders and their subcontractors/suppliers must not have restrictions related to EU sanctions.
--Must comply with the exclusion grounds described in the ESPD.
ELIGIBILITY REQUIREMENTS2
--Must meet the qualification conditions described in the ESPD.
--The successful bidder must agree to the terms of the draft sales contract.
TECHNICAL CAPABILITY REQUIREMENTS2
--The contracting authority's preference for medicinal products with a marketing authorization must be considered.
--The bid must comply with the technical specification provided in Form 2.
FINANCIAL REQUIREMENTS2
--The primary criterion for bid evaluation is the lowest 24-month estimated cost without taxes.
--The bidder must fill in the yellow cells in Form 2 with unit prices, which will be fixed for the entire framework agreement period.

Aperçu des exigences

Inscrivez-vous pour consulter les exigences et l'analyse complètes

Documents

7 documents disponibles avec des résumés IA

VastavustingimusedPDF
306019_vastavustingimused.pdf -- 138.3 KB

This document outlines tender submission requirements, including filling out Forms 1 and 2, restrictions on subcontractors and suppliers due to EU sanctions, and conditions for joint bidders' power of attorney and marking business secrets.

Vorm 1DOC
Vorm 1 - riigihankes osalemise avaldus.doc -- 40.5 KB

Tender document 'Vorm 1' in .DOC format (41,472 bytes).

Vorm 2XLS
Vorm 2 - Tehniline kirjeldus_hinnajaotustabel... -- 31.4 KB

This document is a fillable form containing a technical description and price breakdown table, where the bidder must complete the yellow cells with unit prices that will be fixed for the entire framework agreement period, and consider the contracting authority's preference for medicinal products with marketing authorization.

Hindamiskriteeriumid ja hinnatavad näitajadPDF
306019_hindamiskriteeriumid.pdf -- 37.8 KB

This document outlines the tender evaluation criteria and methodology, primarily based on the lowest 24-month estimated cost without taxes.

Hankepass täiendatavate selgitustegaPDF
306019_hankepass_taiendavate_selgitustega.pdf -- 63.9 KB

This document is an explanatory Hankepass (ESPD) detailing the contracting authority's conditions and requirements for the tender, serving as a guide for bidders to understand qualification criteria and exclusion grounds, but it is not to be filled out directly.

AlusdokumendidDOC
Alusdokumendid.docx -- 45.6 KB

These base documents provide an overview of the general conditions of the public procurement, the e-procurement process, rules for submitting offers, and refer to important appendices and forms.

Müügilepingu projektDOC
Müügilepingu projekt.docx -- 37.0 KB

This document is a draft sales contract outlining the terms for the purchase of medicines by Lääne-Tallinna Keskhaigla and other hospitals from the successful tenderer, based on the tender documents and the bidder's offer.

Aperçu des documents

Inscrivez-vous pour consulter les résumés et l'analyse des documents

76
Bon

Score de qualité de l'appel d'offres

This tender is generally well-structured and transparent, but it presents a significant inconsistency between the stated procedure type and the allowance for negotiation, which requires clarification. It provides comprehensive documentation and clear evaluation criteria.

Répartition du score

Conformité légale70/100

The deadlines are reasonable, and references to ESPD and EU sanctions are present. However, the primary concern is the 'Negotiation Allowed' characteristic listed for an 'Open Procedure' (Type A), which is contradictory and could lead to legal challenges or confusion regarding the procurement process.

Inconsistency between 'Open Procedure' (Type A) and 'Negotiation Allowed'.
Clarté85/100

The description, requirements, and evaluation criteria are generally clear and understandable. Documentation is comprehensive, including specific forms and a draft contract. A minor ambiguity arises from the 'Negotiation Allowed' characteristic conflicting with the stated procedure type.

Slight ambiguity due to 'Negotiation Allowed' in an 'Open Procedure'.
Exhaustivité80/100

Basic information, deadlines, value, and duration (24 months) are all specified. Documents are attached, and requirements are defined. However, the NUTS code is missing, and the explicit delivery location is not detailed in the basic information, though implied by the organization and contract.

Missing NUTS code.
Explicit delivery location not detailed in basic information.
Équité90/100

Full document access is provided, the estimated value is disclosed, and the evaluation criteria (lowest cost) are objective and transparent. Electronic submission is enabled, and requirements appear generic, not tailored. The tender being 'Divided into Parts' also promotes fair competition.

Aspect pratique80/100

Electronic submission is supported, and the duration is clearly specified as 24 months. While the exact contract start date is not explicitly in the basic info, this is often determined post-award. Financing conditions refer to the contract, which is provided.

Contract start date not explicitly stated in basic information.
Cohérence des données70/100

Most key fields are populated, and dates are logical and consistent. The significant inconsistency lies in the 'Type: A' (Open Procedure) being listed alongside 'Negotiation Allowed', which represents a fundamental contradiction in the procurement process definition.

Inconsistency between procedure type ('Open Procedure') and 'Negotiation Allowed'.
Durabilité30/100

There are no explicit mentions of green procurement, social aspects, or innovation focus within the provided tender information or AI summaries. The tender is not specified as EU funded.

Absence of explicit green procurement, social, or innovation criteria.

Points forts

Clear financial requirements and objective evaluation criteria (lowest cost).
Comprehensive documentation, including draft contract and specific forms.
High transparency with disclosed value and electronic submission.
Reasonable submission deadline and tender divided into parts.
E-procurement enabled for equal access.

Préoccupations

Significant inconsistency between 'Open Procedure' and 'Negotiation Allowed', requiring urgent clarification.
Lack of explicit sustainability, social, or innovation criteria.
Missing NUTS code and explicit delivery location in the basic information.

Recommandations

1. Clarify the procedure type and whether negotiation is truly permitted, ensuring consistency with national procurement regulations.
2. Consider incorporating sustainability, social, or innovation criteria where feasible, even for medical supplies, to align with modern procurement best practices.
3. Ensure all standard fields like NUTS code and explicit delivery location are populated for full completeness.

Aperçu de la notation IA

Inscrivez-vous pour consulter les exigences et l'analyse complètes

Analyse complète du score de qualité
Répartition détaillée des sous-scores
Aperçu des forces et des préoccupations
Recommandations stratégiques

Aucune carte de crédit requise • Configuration en 2 minutes

Ajouter au Pipeline